| Aurora Health Center | |
| N84w16889 Menomonee Ave, Menomonee Falls, Wisconsin 53051 | |
| (262) 251-7500 |
| Name | Aurora Health Center |
|---|---|
| Organization Name | Aurora Advanced Healthcare, Inc. |
| Location | N84w16889 Menomonee Ave, Menomonee Falls, Wisconsin 53051 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (262) 251-7500 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In vitro toxicity testing is rapidly being adopted in the pharmaceutical, chemical, and cosmetics industries, for example, as an alternative to animal studies to predict adverse health effects of drugs and personal care products and the health consequences of environmental exposures.
Scientists at St. Jude Children's Research Hospital have gained new insights into regulation of one of the body's enzyme workhorses called calpains.
A clinical trial found that the use of a next generation, micronet, mesh-covered stent demonstrated improved restoration of blood flow to heart tissue, compared to the use of either bare-metal or drug-eluting stents in heart attack patients undergoing angioplasty.
The Centers for Medicare & Medicaid Services (CMS) in the United States have given approval for new sleep test to diagnose obstructive sleep apnea (OSA).
The Board of Directors of CELLINK AB (publ) has, based on the authorization given by the Company's Annual General Meeting that was held on 18 December 2019, resolved on a directed share issue of 3,890,000 new shares of series B (corresponding to approximately 10 per cent of the total number of outstanding shares in the Company) at a subscription price of SEK 97 per share (the "Share Issue"), which means that the Company receives SEK 377,330,000 before transaction costs.
› Verified 5 days ago
| NPI Number | 1083794176 |
| Organization Name | ADVANCED HEALTHCARE, S.C. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | N84w16889 Menomonee Ave, Menomonee Falls, WI 53051 |
| Phone Number | 262-251-7500 |
News Archive
In vitro toxicity testing is rapidly being adopted in the pharmaceutical, chemical, and cosmetics industries, for example, as an alternative to animal studies to predict adverse health effects of drugs and personal care products and the health consequences of environmental exposures.
Scientists at St. Jude Children's Research Hospital have gained new insights into regulation of one of the body's enzyme workhorses called calpains.
A clinical trial found that the use of a next generation, micronet, mesh-covered stent demonstrated improved restoration of blood flow to heart tissue, compared to the use of either bare-metal or drug-eluting stents in heart attack patients undergoing angioplasty.
The Centers for Medicare & Medicaid Services (CMS) in the United States have given approval for new sleep test to diagnose obstructive sleep apnea (OSA).
The Board of Directors of CELLINK AB (publ) has, based on the authorization given by the Company's Annual General Meeting that was held on 18 December 2019, resolved on a directed share issue of 3,890,000 new shares of series B (corresponding to approximately 10 per cent of the total number of outstanding shares in the Company) at a subscription price of SEK 97 per share (the "Share Issue"), which means that the Company receives SEK 377,330,000 before transaction costs.
› Verified 5 days ago
| NPI Number | 1336337286 |
| Organization Name | AURORA ADVANCED HEALTHCARE, INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | N84w16889 Menomonee Ave, Menomonee Falls, WI 53051 |
| Phone Number | 262-251-2299 |
News Archive
In vitro toxicity testing is rapidly being adopted in the pharmaceutical, chemical, and cosmetics industries, for example, as an alternative to animal studies to predict adverse health effects of drugs and personal care products and the health consequences of environmental exposures.
Scientists at St. Jude Children's Research Hospital have gained new insights into regulation of one of the body's enzyme workhorses called calpains.
A clinical trial found that the use of a next generation, micronet, mesh-covered stent demonstrated improved restoration of blood flow to heart tissue, compared to the use of either bare-metal or drug-eluting stents in heart attack patients undergoing angioplasty.
The Centers for Medicare & Medicaid Services (CMS) in the United States have given approval for new sleep test to diagnose obstructive sleep apnea (OSA).
The Board of Directors of CELLINK AB (publ) has, based on the authorization given by the Company's Annual General Meeting that was held on 18 December 2019, resolved on a directed share issue of 3,890,000 new shares of series B (corresponding to approximately 10 per cent of the total number of outstanding shares in the Company) at a subscription price of SEK 97 per share (the "Share Issue"), which means that the Company receives SEK 377,330,000 before transaction costs.
› Verified 5 days ago
| NPI Number | 1457430258 |
| Organization Name | ADVANCED HEALTHCARE, S.C. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | N84w16889 Menomonee Ave, Menomonee Falls, WI 53051 |
| Phone Number | 262-251-7500 |
News Archive
In vitro toxicity testing is rapidly being adopted in the pharmaceutical, chemical, and cosmetics industries, for example, as an alternative to animal studies to predict adverse health effects of drugs and personal care products and the health consequences of environmental exposures.
Scientists at St. Jude Children's Research Hospital have gained new insights into regulation of one of the body's enzyme workhorses called calpains.
A clinical trial found that the use of a next generation, micronet, mesh-covered stent demonstrated improved restoration of blood flow to heart tissue, compared to the use of either bare-metal or drug-eluting stents in heart attack patients undergoing angioplasty.
The Centers for Medicare & Medicaid Services (CMS) in the United States have given approval for new sleep test to diagnose obstructive sleep apnea (OSA).
The Board of Directors of CELLINK AB (publ) has, based on the authorization given by the Company's Annual General Meeting that was held on 18 December 2019, resolved on a directed share issue of 3,890,000 new shares of series B (corresponding to approximately 10 per cent of the total number of outstanding shares in the Company) at a subscription price of SEK 97 per share (the "Share Issue"), which means that the Company receives SEK 377,330,000 before transaction costs.
› Verified 5 days ago
| NPI Number | 1558558460 |
| Organization Name | AURORA ADVANCED HEALTHCARE, INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | N84w16889 Menomonee Ave, Menomonee Falls, WI 53051 |
| Phone Number | 262-251-7500 |
News Archive
In vitro toxicity testing is rapidly being adopted in the pharmaceutical, chemical, and cosmetics industries, for example, as an alternative to animal studies to predict adverse health effects of drugs and personal care products and the health consequences of environmental exposures.
Scientists at St. Jude Children's Research Hospital have gained new insights into regulation of one of the body's enzyme workhorses called calpains.
A clinical trial found that the use of a next generation, micronet, mesh-covered stent demonstrated improved restoration of blood flow to heart tissue, compared to the use of either bare-metal or drug-eluting stents in heart attack patients undergoing angioplasty.
The Centers for Medicare & Medicaid Services (CMS) in the United States have given approval for new sleep test to diagnose obstructive sleep apnea (OSA).
The Board of Directors of CELLINK AB (publ) has, based on the authorization given by the Company's Annual General Meeting that was held on 18 December 2019, resolved on a directed share issue of 3,890,000 new shares of series B (corresponding to approximately 10 per cent of the total number of outstanding shares in the Company) at a subscription price of SEK 97 per share (the "Share Issue"), which means that the Company receives SEK 377,330,000 before transaction costs.
› Verified 5 days ago
News Archive
In vitro toxicity testing is rapidly being adopted in the pharmaceutical, chemical, and cosmetics industries, for example, as an alternative to animal studies to predict adverse health effects of drugs and personal care products and the health consequences of environmental exposures.
Scientists at St. Jude Children's Research Hospital have gained new insights into regulation of one of the body's enzyme workhorses called calpains.
A clinical trial found that the use of a next generation, micronet, mesh-covered stent demonstrated improved restoration of blood flow to heart tissue, compared to the use of either bare-metal or drug-eluting stents in heart attack patients undergoing angioplasty.
The Centers for Medicare & Medicaid Services (CMS) in the United States have given approval for new sleep test to diagnose obstructive sleep apnea (OSA).
The Board of Directors of CELLINK AB (publ) has, based on the authorization given by the Company's Annual General Meeting that was held on 18 December 2019, resolved on a directed share issue of 3,890,000 new shares of series B (corresponding to approximately 10 per cent of the total number of outstanding shares in the Company) at a subscription price of SEK 97 per share (the "Share Issue"), which means that the Company receives SEK 377,330,000 before transaction costs.
› Verified 5 days ago
Aurora Health Center Type: Durable Medical Equipment & Medical Supplies Supplier Location: N84w16889 Menomonee Ave, Menomonee Falls, Wisconsin 53051 Phone: (262) 251-7500 | |
Aurora Vision Center-menomonee Fall Type: Eyewear Supplier (Equipment, not the service) Location: N84w16889 Menomonee Ave, Menomonee Falls, Wisconsin 53051 Phone: (262) 251-2299 | |
Aurora Pharmacy Inc. Type: Clinic Pharmacy Location: N84w16889 Menomonee Ave, Menomonee Falls, Wisconsin 53051 Phone: (262) 251-8500 | |
Bioresolutions Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: N56w16688 Ridgewood Dr, Menomonee Falls, Wisconsin 53051 Phone: (262) 820-0289 | |
Cvs Pharmacy # 03108 Type: Durable Medical Equipment & Medical Supplies Supplier Location: W 165 N 5595 Creekwood Crossing, Menomonee Falls, Wisconsin 53051 Phone: (262) 703-3386 |